Skip to content
Homepage
Author:
Xentria, Inc.
Posted Date:
September 1, 2026
Xentria Advances XTMAB-16 Clinical Development in Pulmonary Sarcoidosis Following FDA Feedback
Xentria, Inc.
September 1, 2026
